Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE
- DOI
- 10.1016/j.breast.2026.104883
- Published
- 2026-10
- Container
- The Breast
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2026.104883,
title = {Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE},
author = {Kazuki Nozawa and Hiroji Iwata and Toru Mukohara and Tetsuhiko Taira and Akiyo Yoshimura and Shigenori E. Nagai and Jun Hashimoto and Kazuo Matsuura and Toshiro Mizuno and Yoshiaki Shinden and Mitsugu Yamamoto and Toshimi Takano and Makoto Wakahara and Hirofumi Terakawa and Takashi Yamanaka and Yasuyuki Kojima and Takahiro Nakayama and Yuji Hirakawa and Kazuhito Shiosakai and Junji Tsurutani},
year = {2026},
journal = {The Breast},
doi = {10.1016/j.breast.2026.104883},
url = {https://doi.org/10.1016/j.breast.2026.104883}
}RIS
TY - JOUR TI - Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE AU - Kazuki Nozawa AU - Hiroji Iwata AU - Toru Mukohara AU - Tetsuhiko Taira AU - Akiyo Yoshimura AU - Shigenori E. Nagai AU - Jun Hashimoto AU - Kazuo Matsuura AU - Toshiro Mizuno AU - Yoshiaki Shinden AU - Mitsugu Yamamoto AU - Toshimi Takano AU - Makoto Wakahara AU - Hirofumi Terakawa AU - Takashi Yamanaka AU - Yasuyuki Kojima AU - Takahiro Nakayama AU - Yuji Hirakawa AU - Kazuhito Shiosakai AU - Junji Tsurutani PY - 2026 JO - The Breast DO - 10.1016/j.breast.2026.104883 UR - https://doi.org/10.1016/j.breast.2026.104883 ER -
APA
Nozawa, K., Iwata, H., Mukohara, T., Taira, T., Yoshimura, A., Nagai, S. E., Hashimoto, J., Matsuura, K., Mizuno, T., Shinden, Y., Yamamoto, M., Takano, T., Wakahara, M., Terakawa, H., Yamanaka, T., Kojima, Y., Nakayama, T., Hirakawa, Y., Shiosakai, K., & Tsurutani, J. (2026). Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE. The Breast. https://doi.org/10.1016/j.breast.2026.104883
Source records
- crossref · retrieved 2026-09-26T09:00:57.657Z